NCT03968510

Brief Summary

Swallow related quality of life before and after parathyroidectomy will be evaluated in patients with primary hyperparathyridism.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2018

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 20, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 30, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2020

Completed
Last Updated

June 4, 2021

Status Verified

June 1, 2021

Enrollment Period

1.7 years

First QC Date

March 20, 2019

Last Update Submit

June 1, 2021

Conditions

Hyperparathyroidism

Outcome Measures

Primary Outcomes (1)

  • Change in quality of life

    Quality of life will be evaluated using short form 36

    6 months

Study Arms (1)

parathyroidectomy cases

patients who will be operated for primary hyperparathyroidism

Procedure: parathyroidectomy

Interventions

parathyroidectomyPROCEDURE

routine parathyroidectomy will be done for the treatment of adenoma

parathyroidectomy cases

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients with primary hyperparathyroidism

You may qualify if:

  • no diagnosis of Alzheimers disease
  • must be able to swallow tablets Planned operation for primary hyperparathyroidism

You may not qualify if:

  • secondary or tertiary hyperparathyroidism
  • insulin dependent diabetes
  • thyroid disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uşak University

Uşak, 64100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hyperparathyroidism

Interventions

Parathyroidectomy

Condition Hierarchy (Ancestors)

Parathyroid DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Endocrine Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Barış Sevinç

    Uşak University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

March 20, 2019

First Posted

May 30, 2019

Study Start

November 1, 2018

Primary Completion

July 1, 2020

Study Completion

November 1, 2020

Last Updated

June 4, 2021

Record last verified: 2021-06

Locations

TU(1)